PharmaShots | Incisive News in 3 Shots

Subscribe Now

investigational

Bausch Health Initiates Second P-III Study for NOV03 (perfluorohexyloctane) to Treat DED Associated With MGD

Bausch Health Initiates Second P-III Study for NOV03 (perfluorohexyloctane) to Treat DED Associated With MGD

November 25, 2020

Janssen's Investigational Prophylactic Vaccine Receives the US FDA's Breakthrough Therapy Designation to Prevent Respiratory Syncytial Virus

Janssen's Investigational Prophylactic Vaccine Receives the US FDA's Breakthrough Therapy Designation to Prevent Respiratory Syncy...

September 4, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us